Tower Research Capital LLC (Trc) Verastem, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.33 - $10.44 $5,929 - $187,575	17,967 Added 214.94%	26,326 $11,000
Q3 2022 Nov 10, 2022	SELL	$0.92 - $11.16 $1,764 - $21,404	-1,918 Reduced 18.66%	8,359 $7,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $23,030 - $41,319	-22,579 Reduced 68.72%	10,277 $12,000
Q1 2022 May 12, 2022	SELL	$1.06 - $2.1 $25,109 - $49,744	-23,688 Reduced 41.89%	32,856 $46,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $88,812 - $138,633	43,323 Added 327.68%	56,544 $116,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $8,552 - $13,703	-3,367 Reduced 20.3%	13,221 $41,000
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $11,690 - $22,062	4,549 Added 37.79%	16,588 $68,000
Q1 2021 May 17, 2021	SELL	$1.9 - $2.82 $34,682 - $51,476	-18,254 Reduced 60.26%	12,039 $30,000
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $152,015 - $317,248	-132,187 Reduced 81.36%	30,293 $64,000
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $17,361 - $26,276	15,641 Added 10.65%	162,480 $196,000
Q2 2020 Aug 13, 2020	BUY	$1.69 - $4.2 $238,859 - $593,615	141,337 Added 2568.83%	146,839 $253,000
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $6,932 - $18,596	5,502 New	5,502 $15,000
Q4 2019 Feb 07, 2020	SELL	$0.86 - $1.44 $154 - $259	-180 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$1.21 - $1.59 $21,064 - $27,680	-17,409 Reduced 98.98%	180 $0
Q2 2019 Aug 13, 2019	BUY	$1.25 - $3.14 $21,286 - $53,471	17,029 Added 3040.89%	17,589 $27,000
Q1 2019 May 14, 2019	BUY	$2.79 - $4.09 $1,562 - $2,290	560 New	560 $2,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $18,369 - $39,865	-5,687 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.86 - $9.97 $39,012 - $56,699	5,687 New	5,687 $41,000
Q2 2018 Aug 15, 2018	SELL	$2.88 - $8.67 $1,814 - $5,462	-630 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.92 - $3.81 $20,232 - $26,399	-6,929 Reduced 91.67%	630 $2,000
Q4 2017 Feb 09, 2018	BUY	$2.99 - $4.85 $20,870 - $33,853	6,980 Added 1205.53%	7,559 $23,000
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $1,742 - $3,132	579	579 $3,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$897,750
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$191,520
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$79,800
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$11,910
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$4,285
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account